{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:39:40Z","timestamp":1784918380791,"version":"3.55.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11010-019-03656-y","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T03:03:02Z","timestamp":1574996582000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Role of oxidative stress-related biomarkers in heart failure: galectin 3, \u03b11-antitrypsin and LOX-1: new therapeutic perspective?"],"prefix":"10.1007","volume":"464","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-0423","authenticated-orcid":false,"given":"Valter","family":"Lubrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Balzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"3656_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000313714","volume":"164","author":"A Palazzuoli","year":"2010","unstructured":"Palazzuoli A, Nuti R (2010) Heart failure: pathophysiology and clinical picture. Contrib Nephrol 164:1\u201310. https:\/\/doi.org\/10.1159\/000313714","journal-title":"Contrib Nephrol"},{"key":"3656_CR2","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/eurheartj\/ehv132","volume":"36","author":"S Lim","year":"2015","unstructured":"Lim S, Lam CS, Segers VF et al (2015) Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction. Eur Heart J 36:2050\u20132060. https:\/\/doi.org\/10.1093\/eurheartj\/ehv132","journal-title":"Eur Heart J"},{"key":"3656_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodelling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263\u2013267. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.092","journal-title":"J Am Coll Cardiol"},{"key":"3656_CR4","first-page":"2927","volume":"18","author":"RR Sun","year":"2014","unstructured":"Sun RR, Lu L, Liu M et al (2014) Biomarkers and heart disease. Eur Rev Med Pharmacol Sci 18:2927\u20132935","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3656_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10557-014-6520-2","volume":"28","author":"RA De Boer","year":"2014","unstructured":"De Boer RA, Van der Velde AR, Mueller C et al (2014) Galectin-3: a modifiable risk factor in heart failure. Cardiovasc Drugs Ther 28:237\u2013246. https:\/\/doi.org\/10.1007\/s10557-014-6520-2","journal-title":"Cardiovasc Drugs Ther"},{"key":"3656_CR6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2459\/JCM.0000000000000016","volume":"18","author":"V Lubrano","year":"2017","unstructured":"Lubrano V, Papa A, Pingitore A et al (2017) Alpha-1 protein evaluation to stratify heart failure patients. J Cardiovasc Med 18:774\u2013776. https:\/\/doi.org\/10.2459\/JCM.0000000000000016","journal-title":"J Cardiovasc Med"},{"key":"3656_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/s0006-291x(02)02905-4","volume":"300","author":"K Kataoka","year":"2003","unstructured":"Kataoka K, Hasegawa K, Sawamura T et al (2003) LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 300:656\u2013660. https:\/\/doi.org\/10.1016\/s0006-291x(02)02905-4","journal-title":"Biochem Biophys Res Commun"},{"key":"3656_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCRESAHA.107.162800","volume":"102","author":"AK Doughan","year":"2008","unstructured":"Doughan AK, Harrison DG, Dikalov SI (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102:488\u2013496. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.162800","journal-title":"Circ Res"},{"key":"3656_CR9","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/s0735-1097(03)00471-6","volume":"41","author":"C Heymes","year":"2003","unstructured":"Heymes C, Bendall JK, Ratajczak P et al (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41:2164\u20132171. https:\/\/doi.org\/10.1016\/s0735-1097(03)00471-6","journal-title":"J Am Coll Cardiol"},{"key":"3656_CR10","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1161\/hc4501.098928","volume":"104","author":"TP Cappola","year":"2001","unstructured":"Cappola TP, Kass DA, Nelson GS et al (2001) Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104:2407\u20132411. https:\/\/doi.org\/10.1161\/hc4501.098928","journal-title":"Circulation"},{"key":"3656_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0022-2828(78)90384-X","volume":"10","author":"NS Dhalla","year":"1978","unstructured":"Dhalla NS, Das PK, Sharma GP (1978) Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol 10:363\u2013385","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","volume":"18","author":"NS Dhalla","year":"2000","unstructured":"Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in cardiovascular diseases. J Hypertens 18:655\u2013673. https:\/\/doi.org\/10.1097\/00004872-200018060-00002","journal-title":"J Hypertens"},{"key":"3656_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pharmthera.2009.03.006","volume":"123","author":"LM Blayney","year":"2009","unstructured":"Blayney LM, Lai FA (2009) Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol Ther 123:151\u2013177. https:\/\/doi.org\/10.1016\/j.pharmthera.2009.03.006","journal-title":"Pharmacol Ther"},{"key":"3656_CR14","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.jacc.2007.01.064","volume":"49","author":"M Mochizuki","year":"2007","unstructured":"Mochizuki M, Yano M, Oda T et al (2007) Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+\u2009leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 49:1722\u20131732. https:\/\/doi.org\/10.1016\/j.jacc.2007.01.064","journal-title":"J Am Coll Cardiol"},{"key":"3656_CR15","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.108.184457","volume":"103","author":"D Terentyev","year":"2008","unstructured":"Terentyev D, Gy\u00f6rke I, Belevych AE et al (2008) Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+\u2009leak in chronic heart failure. Circ Res 103:1466\u20131472. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.184457","journal-title":"Circ Res"},{"key":"3656_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mito.2006.11.026","volume":"7","author":"HP Indo","year":"2007","unstructured":"Indo HP, Davidson M, Yen HC et al (2007) Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 7:106\u2013118. https:\/\/doi.org\/10.1016\/j.mito.2006.11.026","journal-title":"Mitochondrion"},{"key":"3656_CR17","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.jacc.2013.01.074","volume":"61","author":"D Hayashi","year":"2013","unstructured":"Hayashi D, Ohshima S, Isobe S et al (2013) Increased (99\u00a0m)Tc-sestamibi washout reflects impaired myocardial contractile and relaxation reserve during dobutamine stress due to mitochondrial dysfunction in dilated cardiomyopathy patients. J Am Coll Cardiol 61:2007\u20132017. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.074","journal-title":"J Am Coll Cardiol"},{"key":"3656_CR18","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1161\/CIRCULATIONAHA.112.001219","volume":"127","author":"P Ahuja","year":"2013","unstructured":"Ahuja P, Wanagat J, Wang Z et al (2013) Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation 127:1957\u20131967. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.001219","journal-title":"Circulation"},{"key":"3656_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","volume":"75","author":"EM Redout","year":"2007","unstructured":"Redout EM, Wagner MJ, Zuidwijk MJ et al (2007) Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res 75:770\u2013781. https:\/\/doi.org\/10.1016\/j.cardiores.2007.05.012","journal-title":"Cardiovasc Res"},{"key":"3656_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.112.265819","volume":"111","author":"DA Kubli","year":"2012","unstructured":"Kubli DA, Gustafsson \u00c5B (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 111:1208\u20131221. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.265819","journal-title":"Circ Res"},{"key":"3656_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4161\/auto.7.3.14502","volume":"7","author":"K Wang","year":"2011","unstructured":"Wang K, Klionsky DJ (2011) Mitochondria removal by autophagy. Autophagy 7:297\u2013300. https:\/\/doi.org\/10.4161\/auto.7.3.14502","journal-title":"Autophagy"},{"key":"3656_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0008-6363(98)00033-9","volume":"38","author":"HM Piper","year":"1998","unstructured":"Piper HM, Garc\u00eda-Dorado DM et al (1998) A fresh look at reperfusion injury. Cardiovasc Res 38:291\u2013300. https:\/\/doi.org\/10.1016\/s0008-6363(98)00033-9","journal-title":"Cardiovasc Res"},{"key":"3656_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.carpath.2005.03.006","volume":"14","author":"LM Buja","year":"2005","unstructured":"Buja LM (2005) Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 14:170\u2013175. https:\/\/doi.org\/10.1016\/j.carpath.2005.03.006","journal-title":"Cardiovasc Pathol"},{"key":"3656_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","volume":"102","author":"H Bulluck","year":"2016","unstructured":"Bulluck H, Yellon DM, Hausenloy DJ (2016) Reducing myocardial infarct size: challenges and future opportunities. Heart 102:341\u2013348. https:\/\/doi.org\/10.1136\/heartjnl-2015-307855","journal-title":"Heart"},{"key":"3656_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pharmthera.2011.11.004","volume":"133","author":"K Raedschelders","year":"2012","unstructured":"Raedschelders K, Ansley DM, Chen DD (2012) The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133:230\u2013255. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.11.004","journal-title":"Pharmacol Ther"},{"key":"3656_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/s0735-1097(96)00574-8","volume":"9","author":"N Khaper","year":"1997","unstructured":"Khaper N, Singal PK (1997) Effects of after load-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol 9:856\u2013861. https:\/\/doi.org\/10.1016\/s0735-1097(96)00574-8","journal-title":"J Am Coll Cardiol"},{"key":"3656_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1025448908694","volume":"251","author":"N Khaper","year":"2003","unstructured":"Khaper N, Kaur K, Li T et al (2003) Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem 251:9\u201315","journal-title":"Mol Cell Biochem"},{"key":"3656_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.yjmcc.2007.06.010","volume":"43","author":"C Adamy","year":"2007","unstructured":"Adamy C, Mulder P, Khouzami L et al (2007) Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats. J Mol Cell Cardiol 43:344\u2013353. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.06.010","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","volume":"57","author":"DM Townsend","year":"2003","unstructured":"Townsend DM, Tew KD, Tapiero H (2003) The importance of glutathione in human disease. Biomed Pharmacother 57:145\u2013155","journal-title":"Biomed Pharmacother"},{"key":"3656_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/01.RES.0000200181.59551.71","volume":"98","author":"KM Minhas","year":"2006","unstructured":"Minhas KM, Saraiva RM, Schuleri KH et al (2006) Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 98:271\u2013279. https:\/\/doi.org\/10.1161\/01.RES.0000200181.59551.71","journal-title":"Circ Res"},{"key":"3656_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/01.cir.103.5.750","volume":"103","author":"T Ukai","year":"2001","unstructured":"Ukai T, Cheng CP, Tachibana H et al (2001) Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure. Circulation 103:750\u2013755. https:\/\/doi.org\/10.1161\/01.cir.103.5.750","journal-title":"Circulation"},{"key":"3656_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1172\/JCI21968","volume":"115","author":"E Takimoto","year":"2005","unstructured":"Takimoto E, Champion HC, Li M et al (2005) Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodelling from chronic pressure load. J Clin Invest 115:1221\u20131231. https:\/\/doi.org\/10.1172\/JCI21968","journal-title":"J Clin Invest"},{"key":"3656_CR33","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1073\/pnas.95.8.4556","volume":"95","author":"P Wang","year":"1998","unstructured":"Wang P, Chen H, Qin H et al (1998) Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents post ischemic injury. Proc Natl Acad Sci USA 95:4556\u20134560. https:\/\/doi.org\/10.1073\/pnas.95.8.4556","journal-title":"Proc Natl Acad Sci USA"},{"key":"3656_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCHEARTFAILURE.109.864785","volume":"3","author":"F Qin","year":"2010","unstructured":"Qin F, Lennon-Edwards S, Lancel S et al (2010) Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodelling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice. Circ Heart Fail 3:306\u2013313. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.864785","journal-title":"Circ Heart Fail"},{"key":"3656_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.cardfail.2007.07.002","volume":"13","author":"M Hamblin","year":"2007","unstructured":"Hamblin M, Smith HM, Hill MF (2007) Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2 alpha and oxidized glutathione. J Card Fail 13:884\u2013892. https:\/\/doi.org\/10.1016\/j.cardfail.2007.07.002","journal-title":"J Card Fail"},{"key":"3656_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12986-017-0224-0","volume":"14","author":"W Li","year":"2017","unstructured":"Li W, Tang R, Ouyang S et al (2017) Folic acid prevents cardiac dysfunction and reduces myocardial fibrosis in a mouse model of high-fat diet-induced obesity. Nutr Metab 14:68. https:\/\/doi.org\/10.1186\/s12986-017-0224-0","journal-title":"Nutr Metab"},{"key":"3656_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","volume":"125","author":"C Cunnington","year":"2012","unstructured":"Cunnington C, Van Assche T, Shirodaria C et al (2012) Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 125:1356\u20131366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.038919","journal-title":"Circulation"},{"key":"3656_CR38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1517\/13543784.13.11.1509","volume":"13","author":"RS Freudenberger","year":"2004","unstructured":"Freudenberger RS, Schwarz RP, Brown J et al (2004) Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III-IV congestive heart failure. Expert Opin Investig Drugs 13:1509\u20131516. https:\/\/doi.org\/10.1517\/13543784.13.11.1509","journal-title":"Expert Opin Investig Drugs"},{"key":"3656_CR39","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","volume":"51","author":"JM Hare","year":"2008","unstructured":"Hare JM, Mangal B, Brown J et al (2008) Impact of oxypurinol in patients with symptomatic heart failure. J Am Coll Cardiol 51:2301\u20132309. https:\/\/doi.org\/10.1016\/j.jacc.2008.01.068","journal-title":"J Am Coll Cardiol"},{"key":"3656_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ijcard.2016.06.253","volume":"220","author":"L Louzao-Martinez","year":"2016","unstructured":"Louzao-Martinez L, Vink A, Harakalova M et al (2016) Characteristic adaptations of the extracellular matrix in dilated cardiomyopathy. Int J Cardiol 220:634\u2013646. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.253","journal-title":"Int J Cardiol"},{"key":"3656_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1159\/000494539","volume":"50","author":"S Al-Salam","year":"2018","unstructured":"Al-Salam S, Hashmi S (2018) Myocardial ischemia reperfusion injury: apoptotic, inflammatory and oxidative stress. Role of galectin-3. Cell Physiol Biochem 50:1123\u20131139. https:\/\/doi.org\/10.1159\/000494539","journal-title":"Cell Physiol Biochem"},{"key":"3656_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1023\/B:GLYC.0000014082.99675.2f","volume":"19","author":"J Ochieng","year":"2002","unstructured":"Ochieng J, Furtak V, Lukyanov P (2002) Extracellular functions of galectin-3. Glycoconj J 19:527\u2013535. https:\/\/doi.org\/10.1023\/B:GLYC.0000014082.99675.2f","journal-title":"Glycoconj J"},{"key":"3656_CR43","first-page":"5272","volume":"57","author":"S Akahani","year":"1997","unstructured":"Akahani S, Nangia-Makker P, Inohara H et al (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57:5272\u20135276","journal-title":"Cancer Res"},{"key":"3656_CR44","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1074\/jbc.273.21.13047","volume":"273","author":"J Seetharaman","year":"1998","unstructured":"Seetharaman J, Kanigsberg A, Slaaby R et al (1998) X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J Biol Chem 273:13047\u201313052. https:\/\/doi.org\/10.1074\/jbc.273.21.13047","journal-title":"J Biol Chem"},{"key":"3656_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0014-5793(01)02586-8","volume":"500","author":"K Bachhawat-Sikder","year":"2001","unstructured":"Bachhawat-Sikder K, Thomas CJ, Surolia A (2001) Thermodynamic analysis of the binding of galactose and poly-N-acetyllactosamine derivatives to human galectin-3. FEBS Lett 500:75\u201379. https:\/\/doi.org\/10.1016\/s0014-5793(01)02586-8","journal-title":"FEBS Lett"},{"key":"3656_CR46","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.1021\/bi00251a020","volume":"33","author":"J Ochieng","year":"1994","unstructured":"Ochieng J, Fridman R, Nangia-Makker P et al (1994) Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33:14109\u201314114. https:\/\/doi.org\/10.1021\/bi00251a020","journal-title":"Biochemistry"},{"key":"3656_CR47","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.4049\/jimmunol.156.4.1572","volume":"156","author":"A Mey","year":"1996","unstructured":"Mey A, Leffler H, Hmama Z et al (1996) The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol 156:1572\u20131577","journal-title":"J Immunol"},{"key":"3656_CR48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<505::AID-JCB14>3.0.CO;2-I","volume":"75","author":"J Ochieng","year":"1999","unstructured":"Ochieng J, Warfield P, Green-Jarvis B et al (1999) Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J Cell Biochem 75:505\u2013514","journal-title":"J Cell Biochem"},{"issue":"2","key":"3656_CR49","doi-asserted-by":"publisher","first-page":"E379","DOI":"10.3390\/ijms19020379","volume":"19","author":"S Sciacchitano","year":"2018","unstructured":"Sciacchitano S, Lavra L, Morgante A et al (2018) One molecule for an alphabet of diseases, from A to Z. Int J Mol Sci 19(2):E379. https:\/\/doi.org\/10.3390\/ijms19020379","journal-title":"Int J Mol Sci"},{"key":"3656_CR50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nri2536","volume":"9","author":"GA Rabinovich","year":"2009","unstructured":"Rabinovich GA, Toscano MA (2009) Turning \u201csweet\u201d on immunity: galectin glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9:338\u2013352. https:\/\/doi.org\/10.1038\/nri2536","journal-title":"Nat Rev Immunol"},{"key":"3656_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cyto.2015.01.016","volume":"73","author":"U Arad","year":"2015","unstructured":"Arad U, Madar-Balakirski N, Angel-Korman A et al (2015) Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts. Cytokine 73:30\u201335. https:\/\/doi.org\/10.1016\/j.cyto.2015.01.016","journal-title":"Cytokine"},{"key":"3656_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ejhf.273","volume":"17","author":"RA De Boer","year":"2015","unstructured":"De Boer RA, Daniels LB, Maisel AS et al (2015) State of the art: newer biomarkers in heart failure. Eur J Heart Fail 17:559\u2013569. https:\/\/doi.org\/10.1002\/ejhf.273","journal-title":"Eur J Heart Fail"},{"issue":"1\u20139","key":"3656_CR53","doi-asserted-by":"publisher","first-page":"e003804","DOI":"10.1161\/CIRCHEARTFAILURE.116.003804","volume":"10","author":"C Besler","year":"2017","unstructured":"Besler C, Lang D, Urban D et al (2017) Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: implications for its use as a biomarker. Circ Heart Fail 10(1\u20139):e003804. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003804","journal-title":"Circ Heart Fail"},{"key":"3656_CR54","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","volume":"186","author":"O Frunza","year":"2016","unstructured":"Frunza O, Russo I, Saxena A et al (2016) Myocardial galectin-3 expression is associated with remodeling of the pressure-overloaded heart and may delay the hypertrophic response without affecting survival, dysfunction and cardiac fibrosis. Am J Pathol 186:1114\u20131127. https:\/\/doi.org\/10.1016\/j.ajpath.2015.12.017","journal-title":"Am J Pathol"},{"issue":"8213","key":"3656_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26115-y","volume":"8","author":"MN Nguyen","year":"2018","unstructured":"Nguyen MN, Su Y, Vizi D et al (2018) Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure. Sci Rep 8(8213):1\u201312. https:\/\/doi.org\/10.1038\/s41598-018-26115-y","journal-title":"Sci Rep"},{"key":"3656_CR56","doi-asserted-by":"publisher","first-page":"40378","DOI":"10.1038\/srep40378","volume":"7","author":"D Hern\u00e1ndez-Romero","year":"2017","unstructured":"Hern\u00e1ndez-Romero D, V\u00edlchez JA, Lahoz \u00c1 et al (2017) Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation. Sci Rep 7:40378. https:\/\/doi.org\/10.1038\/srep40378","journal-title":"Sci Rep"},{"key":"3656_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yjmcc.2015.05.010","volume":"85","author":"C Jaquenod De Giusti","year":"2015","unstructured":"Jaquenod De Giusti C, Ure AE, Rivadeneyra L et al (2015) Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis. J Mol Cell Cardiol 85:58\u201370. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.05.010","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR58","first-page":"41","volume":"3","author":"WF Peacock","year":"2003","unstructured":"Peacock WF (2003) Rapid optimization: strategies for optimal care of decompensated congestive heart failure patients in the emergency department. Rev Cardiovasc Med 3:41\u201348","journal-title":"Rev Cardiovasc Med"},{"key":"3656_CR59","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/ejhf.407","volume":"17","author":"WC Meijers","year":"2015","unstructured":"Meijers WC, De Boer RA, Van Veldhuisen DJ et al (2015) Biomarkers and low risk in heart failure, data from COACH and TRIUMPH. Eur J Heart Fail 17:1271\u20131282. https:\/\/doi.org\/10.1002\/ejhf.407","journal-title":"Eur J Heart Fail"},{"key":"3656_CR60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ahj.2014.02.011","volume":"167","author":"WC Meijers","year":"2014","unstructured":"Meijers WC, Januzzi JL, Adourian AS et al (2014) Elevated plasma galectin-3 is associated with near-term rehospitalisation in heart failure: a pooled analysis of 3 clinical trials. Am Heart J 167:853\u2013860. https:\/\/doi.org\/10.1016\/j.ahj.2014.02.011","journal-title":"Am Heart J"},{"key":"3656_CR61","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","volume":"66","author":"E Mart\u00ednez-Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez-Mart\u00ednez E, Calvier L, Fern\u00e1ndez-Celis A et al (2015) Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension. Hypertension 66:767\u2013775. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05876","journal-title":"Hypertension"},{"key":"3656_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","volume":"3","author":"L Calvier","year":"2015","unstructured":"Calvier L, Martinez-Martinez E, Miana M et al (2015) The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail 3:59\u201367. https:\/\/doi.org\/10.1016\/j.jchf.2014.08.002","journal-title":"JACC Heart Fail"},{"key":"3656_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","volume":"6","author":"L Yu","year":"2013","unstructured":"Yu L, Ruifrok WP, Meissner M et al (2013) Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail 6:107\u2013117. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.971168","journal-title":"Circ Heart Fail"},{"key":"3656_CR64","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/ajpheart.00337.2017","volume":"314","author":"MN Nguyen","year":"2018","unstructured":"Nguyen MN, Su Y, Kiriazis H et al (2018) Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by \u03b22-adrenoceptor overexpression. Am J Physiol Heart Circ Physiol 314:1169\u20131178","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3656_CR65","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jchf.2016.06.010","volume":"4","author":"A Grupper","year":"2016","unstructured":"Grupper A, Nativi-Nicolau J, Maleszewski JJ et al (2016) Circulating galectin-3 levels are persistently elevated after heart transplantation and are associated with renal dysfunction. JACC Heart Fail 4:847\u2013856. https:\/\/doi.org\/10.1016\/j.jchf.2016.06.010","journal-title":"JACC Heart Fail"},{"key":"3656_CR66","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/01.res.54.3.277","volume":"54","author":"SR Jolly","year":"1984","unstructured":"Jolly SR, Kane WJ, Bailie MB et al (1984) Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54:277\u2013285. https:\/\/doi.org\/10.1161\/01.res.54.3.277","journal-title":"Circ Res"},{"key":"3656_CR67","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev.immunol.15.1.351","volume":"15","author":"H Nakamura","year":"1997","unstructured":"Nakamura H, Nakamura K, Yodoi J (1997) Redox regulation of cellular activation. Annual Rev Immunol 15:351\u2013369. https:\/\/doi.org\/10.1146\/annurev.immunol.15.1.351","journal-title":"Annual Rev Immunol"},{"key":"3656_CR68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0022-2828(88)80174-3","volume":"20","author":"C Ceconi","year":"1988","unstructured":"Ceconi C, Curello S, Cargnoni A et al (1988) The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol 20:5\u201313","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR69","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/01.cir.80.6.1795","volume":"80","author":"A Singh","year":"1989","unstructured":"Singh A, Lee KJ, Lee CY et al (1989) Relation between myocardial glutathione content and extent of ischemia-reperfusion injury. Circulation 80:1795\u20131804. https:\/\/doi.org\/10.1161\/01.cir.80.6.1795","journal-title":"Circulation"},{"key":"3656_CR70","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1006\/jmcc.1998.0789","volume":"30","author":"Z Chen","year":"1998","unstructured":"Chen Z, Siu B, Ho YS et al (1998) Overexpression of MnSOD protects against myocardial ischemia\/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30:2281\u20132289. https:\/\/doi.org\/10.1006\/jmcc.1998.0789","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR71","first-page":"II255","volume":"98","author":"YJ Woo","year":"1998","unstructured":"Woo YJ, Zhang JC, Vijayasarathy C et al (1998) Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates post ischemic contractile dysfunction. Circulation 98:II255\u2013II260","journal-title":"Circulation"},{"key":"3656_CR72","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0014-5793(00)01547-7","volume":"473","author":"P Matarrese","year":"2000","unstructured":"Matarrese P, Tinari N, Semeraro ML et al (2000) Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 473:311\u2013315. https:\/\/doi.org\/10.1016\/s0014-5793(00)01547-7","journal-title":"FEBS Lett"},{"key":"3656_CR73","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1432-2277.2008.00705.x","volume":"21","author":"AP Fernandes Bertocchi","year":"2008","unstructured":"Fernandes Bertocchi AP, Campanhole G, Wang PH et al (2008) A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl Int 21:999\u20131007. https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00705.x","journal-title":"Transpl Int"},{"key":"3656_CR74","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.4049\/jimmunol.154.7.3479","volume":"154","author":"A Yamaoka","year":"1995","unstructured":"Yamaoka A, Kuwabara I, Frigeri LG et al (1995) A human lectin, galectin-3 (epsilon bp\/Mac-2), stimulates superoxide production by neutrophils. J Immunol 154:3479\u20133487","journal-title":"J Immunol"},{"key":"3656_CR75","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijmm.2017.3311","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong R, Zhang M, Hu Q et al (2018) Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy. Int J Mol Med 41:599\u2013614. https:\/\/doi.org\/10.3892\/ijmm.2017.3311","journal-title":"Int J Mol Med"},{"key":"3656_CR76","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2217\/bmm-2018-0449","volume":"13","author":"AE Berezin","year":"2019","unstructured":"Berezin AE, Kremzer AA, Samura TA et al (2019) Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes. Biomark Med 13:737\u2013750. https:\/\/doi.org\/10.2217\/bmm-2018-0449","journal-title":"Biomark Med"},{"key":"3656_CR77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2016.04.007","volume":"457","author":"M Beltrami","year":"2016","unstructured":"Beltrami M, Ruocco G, Dastidar AG et al (2016) Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction. Clin Chim Acta 457:99\u2013105. https:\/\/doi.org\/10.1016\/j.cca.2016.04.007","journal-title":"Clin Chim Acta"},{"key":"3656_CR78","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000165117.71483.0C","volume":"111","author":"M Li","year":"2005","unstructured":"Li M, Georgakopoulos D, Lu G et al (2005) p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 111:2494\u20132502. https:\/\/doi.org\/10.1161\/01.CIR.0000165117.71483.0C","journal-title":"Circulation"},{"key":"3656_CR79","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10741-011-9266-y","volume":"17","author":"L Moore","year":"2012","unstructured":"Moore L, Fan D, Basu R et al (2012) Tissue inhibitor of metalloproteinases (TIMPs) in heart failure. Heart Fail Rev 17:693\u2013706. https:\/\/doi.org\/10.1007\/s10741-011-9266-y","journal-title":"Heart Fail Rev"},{"key":"3656_CR80","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2119\/molmed.2011.00196","volume":"18","author":"EC Lewis","year":"2012","unstructured":"Lewis EC (2012) Expanding the clinical indications for \u03b1 (1)-antitrypsin therapy. Mol Med 18:957\u2013970. https:\/\/doi.org\/10.2119\/molmed.2011.00196","journal-title":"Mol Med"},{"key":"3656_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.amjcard.2014.09.043","volume":"115","author":"A Abbate","year":"2015","unstructured":"Abbate A, Van Tassell BW, Christopher S et al (2015) Effects of prolastin C (plasma-derived alpha-1 antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study). Am J Cardiol 115:8\u201312. https:\/\/doi.org\/10.1016\/j.amjcard.2014.09.043","journal-title":"Am J Cardiol"},{"key":"3656_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1465-9921-11-1","volume":"11","author":"JM Duckers","year":"2010","unstructured":"Duckers JM, Shale DJ, Stockley RA et al (2010) Cardiovascular and muscle skeletal co-morbidities in patients with alpha 1 antitrypsin deficiency. Respir Res 11:173. https:\/\/doi.org\/10.1186\/1465-9921-11-1","journal-title":"Respir Res"},{"key":"3656_CR83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2249.1994.tb06523.x","volume":"95","author":"KD Forsyth","year":"1994","unstructured":"Forsyth KD, Talbot V, Beckman I (1994) Endothelial serpins-protectors of the vasculature? Clin Exp Immunol 95:277\u2013282. https:\/\/doi.org\/10.1111\/j.1365-2249.1994.tb06523.x","journal-title":"Clin Exp Immunol"},{"key":"3656_CR84","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1096\/fj.08-127928","volume":"23","author":"G Ortiz-Mu\u00f1oz","year":"2009","unstructured":"Ortiz-Mu\u00f1oz G, Houard X, Mart\u00edn-Ventura JL et al (2009) HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. FASEB J 23:3129\u20133139. https:\/\/doi.org\/10.1096\/fj.08-127928","journal-title":"FASEB J"},{"key":"3656_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-5-11","volume":"5","author":"R Aldonyte","year":"2004","unstructured":"Aldonyte R, Janssson L, Janciauskiene S (2004) Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro. BMC Cell Biol 5:1\u201311. https:\/\/doi.org\/10.1186\/1471-2121-5-11","journal-title":"BMC Cell Biol"},{"key":"3656_CR86","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","volume":"27","author":"S Laurent","year":"2006","unstructured":"Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588\u20132605. https:\/\/doi.org\/10.1093\/eurheartj\/ehl254","journal-title":"Eur Heart J"},{"key":"3656_CR87","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.105.579342","volume":"113","author":"T Willum-Hansen","year":"2006","unstructured":"Willum-Hansen T, Staessen JA, Torp-Pedersen C et al (2006) Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113:664\u2013670. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.579342","journal-title":"Circulation"},{"key":"3656_CR88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/0267659114536760","volume":"30","author":"A Rana","year":"2014","unstructured":"Rana A, Goyal N, Ahlawat A et al (2014) Mechanisms involved in attenuated cardio-protective role of ischemic preconditioning in metabolic disorders. Perfusion 30:94\u2013105. https:\/\/doi.org\/10.1177\/0267659114536760","journal-title":"Perfusion"},{"key":"3656_CR89","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/FJC.0000000000000250","volume":"66","author":"Y Feng","year":"2015","unstructured":"Feng Y, Hu L, Xu Q et al (2015) Cytoprotective role of alpha-1 antitrypsin in vascular endothelial cell under hypoxia\/reoxygenation condition. J Cardiovasc Pharmacol 66:96\u2013107. https:\/\/doi.org\/10.1097\/FJC.0000000000000250","journal-title":"J Cardiovasc Pharmacol"},{"key":"3656_CR90","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.arcmed.2014.01.008","volume":"45","author":"LK Bhatt","year":"2014","unstructured":"Bhatt LK, Veeranjaneyulu A (2014) Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes. Arch Med Res 45:203\u2013209. https:\/\/doi.org\/10.1016\/j.arcmed.2014.01.008","journal-title":"Arch Med Res"},{"key":"3656_CR91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/hrt.49.1.26","volume":"49","author":"H Gilutz","year":"1983","unstructured":"Gilutz H, Siegel Y, Paran E et al (1983) Alpha1-antitrypsin in acute myocardial infarction. Br Heart J 49:26\u201329. https:\/\/doi.org\/10.1136\/hrt.49.1.26","journal-title":"Br Heart J"},{"key":"3656_CR92","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1165\/rcmb.2002-0258OC","volume":"29","author":"J Duranton","year":"2003","unstructured":"Duranton J, Bieth GJ (2003) Inhibition of proteinase-3 by alpha1-antitrypsin in vitro predicts very fast inhibition in vivo. Am J Resp Cell Mol Biol 29:57\u201361. https:\/\/doi.org\/10.1165\/rcmb.2002-0258OC","journal-title":"Am J Resp Cell Mol Biol"},{"key":"3656_CR93","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejheart.2008.01.016","volume":"10","author":"C Banfi","year":"2008","unstructured":"Banfi C, Brioschi M, Barcella S et al (2008) Oxidized proteins in plasma of patients with heart failure: role in endothelial damage. Eur J Heart Fail 10:244\u2013251. https:\/\/doi.org\/10.1016\/j.ejheart.2008.01.016","journal-title":"Eur J Heart Fail"},{"key":"3656_CR94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ccm.2013.10.001","volume":"35","author":"RA Stockley","year":"2014","unstructured":"Stockley RA (2014) Alpha1-antitrypsin review. Clin Chest Med 35:39\u201350. https:\/\/doi.org\/10.1016\/j.ccm.2013.10.001","journal-title":"Clin Chest Med"},{"key":"3656_CR95","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/FJC.0000000000000583","volume":"71","author":"N Abouzaki","year":"2018","unstructured":"Abouzaki N, Christopher S, Benjamin CT et al (2018) Inhibiting the inflammatory injury after myocardial ischemia reperfusion with plasma-derived alpha-1 antitrypsin: a post hoc analysis of the VCU-\u03b11RT Study. J Cardiovasc Pharmacol 71:375\u2013379. https:\/\/doi.org\/10.1097\/FJC.0000000000000583","journal-title":"J Cardiovasc Pharmacol"},{"key":"3656_CR96","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0014-5793(00)01154-6","volume":"467","author":"T Aoyama","year":"2000","unstructured":"Aoyama T, Chen M, Fujiwara H et al (2000) LOX-1 mediates lysophosphatidylcholine induced oxidized LDL uptake in smooth muscle cells. FEBS Lett 467:217\u2013220. https:\/\/doi.org\/10.1016\/s0014-5793(00)01154-6","journal-title":"FEBS Lett"},{"key":"3656_CR97","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1161\/01.ATV.20.4.1107","volume":"20","author":"M Chen","year":"2000","unstructured":"Chen M, Kakutani M, Minami M et al (2000) Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 20:1107\u20131115","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3656_CR98","doi-asserted-by":"publisher","first-page":"10226","DOI":"10.1074\/jbc.M708820200","volume":"283","author":"C Hu","year":"2008","unstructured":"Hu C, Dandapat A, Sun L et al (2008) Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem 283:10226\u201310331. https:\/\/doi.org\/10.1074\/jbc.M708820200","journal-title":"J Biol Chem"},{"key":"3656_CR99","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1161\/01.cir.99.24.3110","volume":"99","author":"H Kataoka","year":"1999","unstructured":"Kataoka H, Kume N, Miyamoto S et al (1999) Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110\u20133117. https:\/\/doi.org\/10.1161\/01.cir.99.24.3110","journal-title":"Circulation"},{"key":"3656_CR100","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11745-008-3227-9","volume":"43","author":"V Lubrano","year":"2008","unstructured":"Lubrano V, Del Turco S, Nicolini G et al (2008) Circulating levels of lectin-like oxidized low-density lipoprotein Receptor-1 are associated with inflammatory markers. Lipids 43:945\u2013950. https:\/\/doi.org\/10.1007\/s11745-008-3227-9","journal-title":"Lipids"},{"key":"3656_CR101","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1253\/circj.cj-09-0488","volume":"74","author":"T Takaya","year":"2010","unstructured":"Takaya T, Wada H, Morimoto T et al (2010) Left ventricular expression of lectin-like oxidized low-density lipoprotein receptor-1 in failing hearts. Circ J 74:723\u2013729. https:\/\/doi.org\/10.1253\/circj.cj-09-0488","journal-title":"Circ J"},{"key":"3656_CR102","doi-asserted-by":"publisher","first-page":"e0154994","DOI":"10.1371\/journal.pone.0154994","volume":"11","author":"C Yokoyama","year":"2016","unstructured":"Yokoyama C, Aoyama T, Ido T et al (2016) Deletion of LOX-1 protects against heart failure induced by doxorubicin. PLoS ONE 11:e0154994. https:\/\/doi.org\/10.1371\/journal.pone.0154994","journal-title":"PLoS ONE"},{"key":"3656_CR103","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1161\/hc4901.100381","volume":"104","author":"E Iwai-Kanai","year":"2001","unstructured":"Iwai-Kanai E, Hasegawa K, Sawamura T et al (2001) Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes. Circulation 104:2948\u20132954. https:\/\/doi.org\/10.1161\/hc4901.100381","journal-title":"Circulation"},{"key":"3656_CR104","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0022-2828(05)82390-9","volume":"27","author":"JP Cleutjens","year":"1995","unstructured":"Cleutjens JP, Kandala JC, Guarda E et al (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281\u20131289","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR105","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yjmcc.2007.10.009","volume":"44","author":"C Hu","year":"2008","unstructured":"Hu C, Chen J, Dandapat A et al (2008) LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J Mol Cell Cardiol 44:76\u201383. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.10.009","journal-title":"J Mol Cell Cardiol"},{"key":"3656_CR106","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1152\/ajpheart.00382.2002","volume":"283","author":"D Li","year":"2002","unstructured":"Li D, Williams V, Liu L et al (2002) LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol 283:1795\u20131801. https:\/\/doi.org\/10.1152\/ajpheart.00382.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3656_CR107","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2143\/AC.71.2.3141848","volume":"71","author":"F Besli","year":"2016","unstructured":"Besli F, Gullulu S, Sag S et al (2016) The relationship between serum lectin-like oxidized LDL receptor-1 levels and systolic heart failure. Acta Cardiol 71:185\u2013190. https:\/\/doi.org\/10.2143\/AC.71.2.3141848","journal-title":"Acta Cardiol"},{"key":"3656_CR108","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","volume":"47","author":"N Kobayashi","year":"2006","unstructured":"Kobayashi N, Yoshida K, Nakano S et al (2006) Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 47:671\u2013679. https:\/\/doi.org\/10.1161\/01.HYP.0000203148.42892.7a","journal-title":"Hypertension"},{"key":"3656_CR109","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00395-017-0650-1","volume":"112","author":"KD Schl\u00fcter","year":"2017","unstructured":"Schl\u00fcter KD, Wolf A, Weber M et al (2017) Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a pro-protein convertase subtilisin\/kexin 9 (PCSK9)-dependent way. Basic Res Cardiol 112:63. https:\/\/doi.org\/10.1007\/s00395-017-0650-1","journal-title":"Basic Res Cardiol"},{"key":"3656_CR110","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.108.115287","volume":"52","author":"C Hu","year":"2008","unstructured":"Hu C, Dandapat A, Sun L et al (2008) Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension 52:556\u2013562. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.115287","journal-title":"Hypertension"},{"key":"3656_CR111","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2005.04.016","volume":"184","author":"J Chen","year":"2006","unstructured":"Chen J, Li D, Schaefer R et al (2006) Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis 184:295\u2013301. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.04.016","journal-title":"Atherosclerosis"},{"key":"3656_CR112","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/01.HYP.0000179045.95915.b0","volume":"46","author":"K Chen","year":"2005","unstructured":"Chen K, Chen J, Liu Y et al (2005) Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids. Hypertension 46:622\u2013627. https:\/\/doi.org\/10.1161\/01.HYP.0000179045.95915.b0","journal-title":"Hypertension"},{"key":"3656_CR113","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1042\/BSR20190788","volume":"2","author":"X Zhang","year":"2019","unstructured":"Zhang X, Dong S, Jia Q et al (2019) The MicroRNA in ventricular remodeling: the miR-30 family. Biosci Rep 2:39. https:\/\/doi.org\/10.1042\/BSR20190788","journal-title":"Biosci Rep"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03656-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03656-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03656-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T13:01:49Z","timestamp":1695474109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03656-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":113,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3656"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03656-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}